| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |